[1] KOZOMARA A,GRIFFITHS-JONES S.miRBase:integrating microRNA annotation and deep-sequencing data[J].Nucleic Acids Res,2011,39 (Database issue):D152-157.
[2] LEWIS B P,BURGE C B,BARTEL D P.Conserved seed pairing,often flanked by adenosines,indicates that thousands of human genes are microRNA targets[J].Cell,2005,120 (1):15-20.
[3] GRIFFITHS-JONES S,GROCOCK R J,van DONGEN S,et al.miRBase:microRNA sequences,targets and gene nomenclature[J].Nucleic Acids Res,2006,34(Database issue):D140-144.
[4] CHO W C.OncomiRs:the discovery and progress of microRNAs in cancers[J].Mol Cancer,2007,6:60.
[5] DIOSDADO B,van de WIEL M A,TERHAAR-SIVE-DROSTE J S,et al.MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression[J].Br J Cancer,2009,101(4):707-714.
[6] SYLVESTRE Y,de GUIRE V,QUERIDO E,et al.An E2F/miR-20a autoregulatory feedback loop[J].J Biol Chem,2007,282(4):2135-2143.
[7] PLACE R F,LI L C,POOKOT D,et al.MicroRNA-373 induces expression of genes with complementary promoter sequences[J].Proc Natl Acad Sci U S A,2008,105(5):1608-1613.
[8] HUANG Q,GUMIREDDY K,SCHRIER M,et al.The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis[J].Nat Cell Biol,2008,10(2):202-210.
[9] HUSEMANN Y,GEIGL J B,SCHUBERT F,et al.Systemic spread is an early step in breast cancer[J].Cancer Cell,2008,13(1):58-68.
[10] MEDINA P P,NOLDE M,SLACK F J.OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma[J].Nature,2010,467(7311):86-90.
[11] MENG F,HENSON R,WEHBE-JANEK H,et al.MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer[J].Gastroenterology,2007,133(2):647-658.
[12] VOLINIA S,GALASSO M,COSTINEAN S,et al.Reprogramming of miRNA networks in cancer and leukemia[J].Genome Res,2010,20(5):589-599.
[13] CIAFRE S A,GALARDI S,MANGIOLA A,et al.Extensive modulation of a set of microRNAs in primary glioblastoma[J].Biochem Biophys Res Commun,2005,334(4):1351-1358.
[14] LI J,HUANG H,SUN L,et al.MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor[J].Clin Cancer Res,2009,15(12):3998-4008.
[15] CERVIGNE N K,REIS P P,MACHADO J,et al.Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma[J].Hum Mol Genet,2009,18(24):4818-4829.
[16] ZHU S,SI M L,WU H,et al.MicroRNA-21 targets the tumor suppressor gene tropomyosin 1(TPM1)[J].J Biol Chem,2007,282(19):14328-14336.
[17] ZHU S,WU H,WU F,et al.MicroRNA-21 targets tumor suppressor genes in invasion and metastasis[J].Cell Res,2008,18(3):350-359.
[18] ASANGANI I A,RASHEED S A,NIKOLOVA D A,et al.MicroRNA-21(miR-21)post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion,intravasation and metastasis in colorectal cancer[J].Oncogene,2008,27(15):2128-2136.
[19] CIMMINO A,CALIN G A,FABBRI M,et al.miR-15 and miR-16 induce apoptosis by targeting BCL2[J].Proc Natl Acad Sci U S A,2005,102(39):13944-13949.
[20] KUMAR M S,ERKELAND S J,PESTER R E,et al.Suppression of non-small cell lung tumor development by the let-7 microRNA family[J].Proc Natl Acad Sci U S A,2008,105(10):3903-3908.
[21] JOHNSON S M,GROSSHANS H,SHINGARA J,et al.RAS is regulated by the let-7 microRNA family[J].Cell,2005,120(5):635-647.
[22] LEE K H,CHEN Y L,YEH S D,et al.MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation[J].Oncogene,2009,28(38):3360-3370.
[23] WELCH C,CHEN Y,STALLINGS R L.MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells[J].Oncogene,2007,26(34):5017-5022.
[24] MOTOYAMA K,INOUE H,TAKATSUNO Y,et al.Over- and under-expressed microRNAs in human colorectal cancer[J].Int J Oncol,2009,34(4):1069-1075.
[25] LIN T,DONG W,HUANG J,et al.MicroRNA-143 as a tumor suppressor for bladder cancer[J].J Urol,2009,181(3):1372-1380.
[26] CHEN X,GUO X,ZHANG H,et al.Role of miR-143 targeting KRAS in colorectal tumorigenesis[J].Oncogene,2009,28(10):1385-1392.
[27] VILLADSEN S B,BRAMSEN J B,OSTENFELD M S,et al.The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer[J].Br J Cancer,2012,106(2):366-374.
[28] LIU L,YU X,GUO X,et al.miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2[J].Mol Med Report,2012,5(3):753-760.
[29] LIU X,CHEN Z,YU J,et al.MicroRNA profiling and head and neck cancer[J].Comp Funct Genomics,2009:837514.
[30] WANG C J,ZHOU Z G,WANG L,et al.Clinicopathological significance of microRNA-31,-143 and -145 expression in colorectal cancer[J].Dis Markers,2009,26(1):27-34.
[31] WONG Q W,LUNG R W,LAW P T,et al.MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1[J].Gastroenterology,2008,135(1):257-269.
[32] WONG T S,LIU X B,WONG B Y,et al.Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue[J].Clin Cancer Res,2008,14(9):2588-2592.
[33] VALASTYAN S,REINHARDT F,BENAICH N,et al.A pleiotropically acting microRNA,miR-31,inhibits breast cancer metastasis[J].Cell,2009,137(6):1032-1046.
[34] GUO J,MIAO Y,XIAO B,et al.Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues[J].J Gastroenterol Hepatol,2009,24(4):652-657.
[35] SCHAEFER A,JUNG M,MOLLENKOPF H J,et al.Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma[J].Int J Cancer,2010,126(5):1166-1176.
[36] VEERLA S,LINDGREN D,KVIST A,et al.MiRNA expression in urothelial carcinomas:important roles of miR-10a,miR-222,miR-125b,miR-7 and miR-452 for tumor stage and metastasis,and frequent homozygous losses of miR-31[J].Int J Cancer,2009,124(9):2236-2242.
[37] LIU X,SEMPERE L F,OUYANG H,et al.MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors[J].J Clin Invest,2010,120(4):1298-1309.
[38] 徐晓峰,周怀君.miRNA-30c的研究进展[J].东南大学学报:医学版,2011,30(3):514-518.
[39] MU Y P,SU X L.Polymorphism in pre-miR-30c contributes to gastric cancer risk in a Chinese population.Med Oncol,2011,doi:10.1007/s12032-011-0115-6.
[40] SELBACH M,SCHWANHAUSSER B,THIERFELDER N,et al. Widespread changes in protein synthesis induced by microRNAs[J].Nature,2008,455(7209):58-63.
[41] HUANG J C,BABAK T,CORSON T W,et al.Using expression profiling data to identify human microRNA targets[J].Nat Methods,2007,4(12):1045-1049.
[42] XIAO F,ZUO Z,CAI G,et al.miRecords:an integrated resource for microRNA-target interactions[J].Nucleic Acids Res,2009,37(Database issue):D105-110.
[43] Computational Biology Center,Memorial Sloan-Kettering Cancer Center.microRNA.org-targets and expression.August 2010 Release(Last Update:2010-11-01)[2012-02-01].http://www.microrna.org.
[44] SIOMI H,SIOMI M C.Posttranscriptional regulation of microRNA biogenesis in animals[J].Mol Cell,2010,38(3):323-332.
[45] LU J,GETZ G,MISKA E A,et al.MicroRNA expression profiles classify human cancers[J].Nature,2005,435(7043):834-838.
[46] BARTEL D P.MicroRNAs:genomics,biogenesis,mechanism,and function[J].Cell,2004,116(2):281-297.
[47] THOMSON J M,NEWMAN M,PARKER J S,et al.Extensive post-transcriptional regulation of microRNAs and its implications for cancer[J].Genes Dev,2006,20(16):2202-2207.
[48] MELO S A,ESTELLER M.A precursor microRNA in a cancer cell nucleus:get me out of here![J].Cell Cycle,2011,10(6):922-925.
[49] GUIL S,CACERES J F.The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a[J].Nat Struct Mol Biol,2007,14(7):591-596.
[50] SUZUKI H I,YAMAGATA K,SUGIMOTO K,et al.Modulation of microRNA processing by p53[J].Nature,2009,460(7254):529-533.
[51] HAGAN J P,PISKOUNOVA E,GREGORY R I.Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells[J].Nat Struct Mol Biol,2009,16(10):1021-1025.
[52] KAWAHARA Y,ZINSHTEYN B,SETHUPATHY P,et al.Redirection of silencing targets by adenosine-to-inosine editing of miRNAs[J].Science,2007,315(5815):1137-1140.
[53] CHEN X,BA Y,MA L,et al.Characterization of microRNAs in serum:a novel class of biomarkers for diagnosis of cancer and other diseases[J].Cell Res,2008,18(10):997-1006.
[54] RESNICK K E,ALDER H,HAGAN J P,et al.The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform[J].Gynecol Oncol,2009,112(1):55-59.
[55] HU Z,DONG J,WANG L E,et al.Serum microRNA profiling and breast cancer risk:the use of miR-484/191 as endogenous controls[J].Carcinogenesis,2012,33(4):828-834.
[56] QI P,CHENG S Q,WANG H,et al.Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection[J].PLoS One,2011,6(12):e28486.
[57] QI P,DOU T H,GENG L,et al.Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection[J].Hum Immunol,2010,71(6):621-626.
[58] MEISTER G,LANDTHALER M,DORSETT Y,et al.Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing[J].Rna,2004,10(3):544-550.
[59] KRUTZFELDT J,RAJEWSKY N,BRAICH R,et al.Silencing of microRNAs in vivo with 'antagomirs’[J].Nature,2005,438(7068):685-689.
[60] KOTA J,CHIVUKULA R R,ODONNELL K A,et al.Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model[J].Cell,2009,137(6):1005-1017.
[61] LIU C,KELNAR K,LIU B,et al.The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44[J].Nat Med,2011,17(2):211-215. |
